Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02475681
Title Elevate CLL TN: Study of Obinutuzumab + Chlorambucil, ACP-196 + Obinutuzumab, and ACP-196 in Subjects With Previously Untreated CLL
Recruitment Unknown status
Gender both
Phase Phase III
Variant Requirements No
Sponsors Acerta Pharma BV
Indications

chronic lymphocytic leukemia

Therapies

Acalabrutinib

Chlorambucil

Obinutuzumab

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.